{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:02:45Z","timestamp":1787162565056,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.semarthrit.2017.07.011","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T17:01:55Z","timestamp":1501779715000},"page":"593-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The value of 18 F-FDG PET\/CT in the distinction between retroperitoneal fibrosis and its malignant mimics"],"prefix":"10.1016","volume":"47","author":[{"given":"Yiwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2017.07.011_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","article-title":"Retroperitoneal fibrosis","volume":"367","author":"Vaglio","year":"2006","journal-title":"The Lancet"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.rdc.2013.02.004","article-title":"Retroperitoneal fibrosis","volume":"39","author":"Scheel","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11739-016-1599-z","article-title":"Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease","volume":"12","author":"Rossi","year":"2017","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1756287214565637","article-title":"Management of idiopathic retroperitoneal fibrosis from the urologist\u2019s perspective","volume":"7","author":"Cristian","year":"2015","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bju.13061","article-title":"A lot of questions (and a few answers ...) in retroperitoneal fibrosis","volume":"117","author":"Fernando","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MD.0b013e3181afc4d1","article-title":"Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis","volume":"88","author":"Vaglio","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.10.046","article-title":"[18F]-fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study","volume":"71","author":"Fernando","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.rdc.2011.09.004","article-title":"Neoplasm mimics of rheumatologic presentations: sialadenitis, ocular masquerade syndromes, retroperitoneal fibrosis, and regional pain syndromes","volume":"37","author":"Lipton","year":"2011","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9343(01)00777-X","article-title":"Sclerosing malignant lymphoma mimicking idiopathic retroperitoneal fibrosis: importance of clonality study","volume":"111","author":"Chim","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib10","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.humpath.2011.01.025","article-title":"Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as retroperitoneal fibrosis","volume":"42","author":"Hammer","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib11","article-title":"Non-Hodgkin lymphoma mimics retroperitoneal fibrosis","volume":"2013","author":"Wan","year":"2013","journal-title":"Case Rep"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-5347(17)61889-5","article-title":"Retroperitoneal malignancy masquerading as benign retroperitoneal fibrosis","volume":"103","author":"Nitz","year":"1970","journal-title":"J Urol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/bjs.1800540602","article-title":"Malignant retroperitoneal fibrosis","volume":"54","author":"Webb","year":"1967","journal-title":"Br J Surg"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib14","article-title":"Gallbladder carcinoma and retroperitoneal fibrosis: a rare combination","volume":"81","author":"Armstrong","year":"1989","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bjc.1973.171","article-title":"Retroperitoneal fibrosis associated with malignant disease","volume":"28","author":"Thomas","year":"1973","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0090-8258(91)90264-6","article-title":"Retroperitoneal fibrosis associated with carcinoma of the cervix: review of the literature","volume":"41","author":"Rivlin","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1464-410X.1986.tb09040.x","article-title":"Retroperitoneal fibrosis with azotaemia secondary to metastatic breast cancer","volume":"58","author":"Srinivas","year":"1986","journal-title":"Br J Urol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0090-4295(77)90198-4","article-title":"Retroperitoneal fibrosis secondary to metastatic neoplasm","volume":"9","author":"Usher","year":"1977","journal-title":"Urology"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e31826b1c1d","article-title":"Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients","volume":"91","author":"Mirault","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1148\/rg.332125085","article-title":"Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up","volume":"33","author":"Caiafa","year":"2013","journal-title":"Radiographics"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2214\/AJR.07.3629","article-title":"Retroperitoneal fibrosis: a review of clinical features and imaging findings","volume":"191","author":"Cronin","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s13075-014-0423-2","article-title":"Clinical value of whole-body PET\/CT in patients with active rheumatic diseases","volume":"16","author":"Yamashita","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib23","first-page":"119","article-title":"Utility of FDG-PET\/CT in the diagnosis of IgG4-related diseases","volume":"34","author":"Zhao","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib24","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/rheumatology\/ket112","article-title":"[18F]FDG uptake in proximal muscles assessed by PET\/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis\/dermatomyositis","volume":"52","author":"Tanaka","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib25","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/rheumatology\/keu147","article-title":"Utility of fluorodeoxyglucose positron emission tomography\/computed tomography for early diagnosis and evaluation of disease activity of relapsing polychondritis: a case series and literature review","volume":"53","author":"Yamashita","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejim.2010.02.008","article-title":"18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis","volume":"21","author":"Jansen","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11604-012-0066-7","article-title":"[(1)(8)F]FDG-PET\/CT in patients affected by retroperitoneal fibrosis: a bicentric experience","volume":"30","author":"Bertagna","year":"2012","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s11739-016-1426-6","article-title":"Diagnosis and follow-up of idiopathic retroperitoneal fibrosis: role of (18)F-FDG-PET\/CT and biochemical parameters in patients with renal involvement","volume":"11","author":"Fofi","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib29","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/ndt\/gfq051","article-title":"Positron emission tomography as a tool for the \u2018tailored\u2019 management of retroperitoneal fibrosis: a nephro-urological experience","volume":"25","author":"Piccoli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/art.20914","article-title":"18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis","volume":"53","author":"Vaglio","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib31","first-page":"231","article-title":"Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent \"scar\" ? A study using 18F-fluorodeoxyglucose positron emission tomography","volume":"23","author":"Vaglio","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/art.21074","article-title":"Positron emission tomography (PET): evaluation of chronic periaortitis","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib33","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib34","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/rheumatology\/keu462","article-title":"IgG4-related periaortitis vs idiopathic periaortitis: is there a role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis?","volume":"54","author":"Castelein","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/RLU.0b013e3182478bd3","article-title":"18F-FDG PET\/CT and contrast-enhanced CT in a one-stop diagnostic procedure: a better strategy for management of patients suffering from retroperitoneal fibrosis?","volume":"37","author":"Guignard","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib36","first-page":"S72","article-title":"Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis","volume":"29","author":"Pipitone","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00296-012-2576-0","article-title":"Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review","volume":"33","author":"Treglia","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib38","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1253\/circj.69.760","article-title":"Retroperitoneal fibrosis with periaortic and pericardial involvement","volume":"69","author":"Amiya","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1510\/icvts.2007.166033","article-title":"Mediastinal fibrosis in a patient with idiopathic retroperitoneal fibrosis","volume":"7","author":"Bahler","year":"2008","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4070\/kcj.2012.42.12.857","article-title":"A case of chronic periaortitis with retroperitoneal fibrosis","volume":"42","author":"Park","year":"2012","journal-title":"Korean Circ J"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1259\/bjr.73.866.10884739","article-title":"Retroperitoneal fibrosis: typical and atypical manifestations","volume":"73","author":"Vivas","year":"2000","journal-title":"Br J Radiol"},{"key":"10.1016\/j.semarthrit.2017.07.011_bib42","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00259-012-2144-6","article-title":"The value of (18)F-FDG PET\/CT in the assessment of active idiopathic retroperitoneal fibrosis","volume":"39","author":"Moroni","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217302640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217302640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T15:27:07Z","timestamp":1535556427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017217302640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0049017217302640"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.07.011","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of 18F-FDG PET\/CT in the distinction between retroperitoneal fibrosis and its malignant mimics","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}